Loading clinical trials...
Loading clinical trials...
The investigator thinks that the oxytocin (OT) can improve durably and significantly the behavior disorders and thus the socialization but also the satisfaction and could thus be an interesting therap...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Hospital, Toulouse
NCT06573723 · Rare Diseases, Amyloidosis, and more
NCT02829684 · Prader-Willi Syndrome
NCT04463316 · Prader-Willi Syndrome, PWS-like Syndrome, and more
NCT06420297 · Hyperphagia in Prader-Willi Syndrome
NCT05701774 · Prader-Willi Syndrome
Centre de référence Prader-Willi - Hôpital Purpan
Toulouse
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions